What is the half-life of risperidone (Risperdal) in a patient with normal liver and kidney function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Risperidone

In patients with normal liver and kidney function, risperidone has a half-life of approximately 3 hours in extensive metabolizers and 20 hours in poor metabolizers, while its active metabolite 9-hydroxyrisperidone has a half-life of approximately 21 hours in extensive metabolizers and 30 hours in poor metabolizers. 1

Understanding the Active Moiety

The clinical effect of risperidone results from the combined concentrations of risperidone plus 9-hydroxyrisperidone, as the metabolite has similar pharmacological activity to the parent drug. 1 This combined "active fraction" has an overall mean elimination half-life of approximately 20 hours, regardless of metabolizer status. 1, 2

Metabolizer Status Impact

The key determinant of risperidone's half-life is CYP 2D6 metabolizer status:

  • Extensive metabolizers: Convert risperidone rapidly to 9-hydroxyrisperidone, resulting in a risperidone half-life of ~3 hours and 9-hydroxyrisperidone half-life of ~21 hours 1, 2

  • Poor metabolizers: Convert risperidone much more slowly, resulting in a risperidone half-life of ~19-20 hours and 9-hydroxyrisperidone half-life of ~30 hours 1, 2

  • Approximately 6-8% of Caucasians and a very low percentage of Asians are poor metabolizers 1

Clinical Implications

Despite the differences in individual component half-lives, the active moiety (risperidone + 9-hydroxyrisperidone) maintains a consistent half-life of approximately 20-23 hours across both metabolizer phenotypes. 1, 2, 3 This allows for:

  • Steady state to be reached within 1 day for risperidone and within 5 days for the active fraction 2
  • Potential for twice-daily or even once-daily dosing based on the 23-hour half-life of the active moiety 3

Important Caveats

Research in Chinese female schizophrenic patients demonstrated a shorter risperidone half-life of 3.2 hours but a longer 9-hydroxyrisperidone half-life of 24.7 hours, with large interindividual variations. 4 This highlights that while the FDA label provides standard values, individual pharmacokinetic parameters can vary considerably, particularly across different ethnic populations. 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.